Dec 8 (Reuters) – Private equity-backed Medline is aiming to raise as much as $5.37 billion in its initial public offering in the United States, the medical supplies provider said on Monday.
The Northfield, Illinois-based company is offering 179 million shares priced between $26 and $30 apiece.
With the Thanksgiving slowdown behind, the U.S. IPO market is poised for a burst of activity in the next fortnight as companies rush to seize the final 2025 window before the holiday lull kicks in.
Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan are the lead bookrunning managers for the offering.
Medline will list on the Nasdaq under the trading symbol “MDLN”.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Alan Barona)
